Figure 6

Figure 6. (6B) Cisplatin dose-response in a static OVCAR-3 culture with and without BPD-PDP (0.03 and 0.05 J/cm2). (6C) Survival fractions in a static OVCAR-3 culture treated with 0.78 µM cisplatin, BPD-PDP at a dose of 0.05 J/cm2 or a combination of thereof. (6D) Survival fractions in a flow OVCAR-3 culture treated with 3.13 µM cisplatin, BPD-PDP at a dose of 0.15 J/cm2 or a combination of thereof. (6E) Survival fractions in a flow OVCAR-3 culture treated with 0.31 µM doxorubicin, BPD-PDP at a dose of 0.15 J/cm2 or a combination of thereof. (6F) Cisplatin dose-response in Caov-3 cells with and without BPD-PDP (0.03 and 0.05 J/cm2). (6G) Survival fractions in a static Caov-3 culture treated with 0.78 µM cisplatin, BPD-PDP at a dose of 0.05 J/cm2 or a combination of thereof. (6H) Survival fractions in a flow Caov-3 culture treated with 3.13 µM cisplatin, BPD-PDP at a dose of 0.1 J/cm2 or a combination of thereof. (6I) Survival fractions in a flow Caov-3 culture treated with 0.16 µM doxorubicin, BPD-PDP at a dose of 0.1 J/cm2 or a combination of thereof.